Health News Roundup: Britain and other nations press on with AstraZeneca vaccine amid trial questions; U.S. CDC reports 262,673 deaths from coronavirus and more

U.S. CDC reports 262,673 deaths from coronavirus The U.S. Centers for Disease Control and Prevention (CDC) on Friday reported 12,823,092 cases of new coronavirus, an increase of 324,358 cases from its previous count, and said the number of deaths had risen by 3,668 to 262,673.


Devdiscourse News Desk | Updated: 28-11-2020 10:56 IST | Created: 28-11-2020 10:31 IST
Health News Roundup: Britain and other nations press on with AstraZeneca vaccine amid trial questions; U.S. CDC reports 262,673 deaths from coronavirus and more
AstraZeneca logo Image Credit: ANI

Following is a summary of current health news briefs.

Britain and other nations press on with AstraZeneca vaccine amid trial questions

Britain asked its regulator on Friday to assess AstraZeneca's COVID-19 vaccine for a possible rollout, while the Philippines and Thailand secured millions of doses, giving the shot a vote of confidence after experts raised questions about trial data. The UK government, which has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University, has targeted a rollout to begin before Christmas.

U.S. CDC reports 262,673 deaths from coronavirus

The U.S. Centers for Disease Control and Prevention (CDC) on Friday reported 12,823,092 cases of new coronavirus, an increase of 324,358 cases from its previous count, and said the number of deaths had risen by 3,668 to 262,673. The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Nov. 26 versus its previous report on Wednesday. (https://bit.ly/33mTSJz)

WHO says it needs to evaluate vaccine candidates on more than just a press release

The World Health Organization needs to evauate coronavirus vaccines and their immune responses based on more than just a press release, Kate O'Brien, WHO's director of immunisation vaccines and biologicals, said on Friday. AstraZeneca is likely to run an additional global trial to assess the efficacy of its vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results of its late-stage study.

Los Angeles County to impose new COVID-19 restrictions on social gatherings

Nearly all social gatherings of individuals from more than a single household will be banned in Los Angeles County for at least three weeks starting Monday under new restrictions local health officials unveiled on Friday, citing a continued surge in COVID-19 infections. The public health order specifically exempts religious services and protests under constitutionally protected rights in an apparent nod to Wednesday's U.S. Supreme Court decision striking down a New York state order that had restricted the size of religious gatherings.

Explainer: Will COVID-19 vaccines protect us? Does efficacy equal effectiveness?

The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials, but what does that mean for the global fight against the pandemic? U.S. drugmakers Pfizer-BioNtech and Moderna have each said their coronavirus vaccines have an efficacy rate of around 95% and a Russian project touted 92% efficacy for its Sputnik V vaccine.

WHO says would be 'highly speculative' to say COVID did not emerge in China

The World Health Organization's top emergency expert said on Friday it would be "highly speculative" for the WHO to say the coronavirus did not emerge in China, where it was first identified in a food market in December last year. China is pushing a narrative via state media that the virus existed abroad before it was discovered in the central city of Wuhan, citing the presence of coronavirus on imported frozen food packaging and scientific papers claiming it had been circulating in Europe last year.

Germany's confirmed coronavirus cases rise by 21,695: RKI

The number of confirmed coronavirus cases in Germany increased by 21,695 to 1,028,089, data from the Robert Koch Institute (RKI) for infectious diseases showed on Saturday. The reported death toll rose by 379 to 15,965, the tally showed.

China reports six new COVID-19 cases vs five a day earlier

China on Saturday reported six new coronavirus cases in the mainland for Nov. 27, compared with five cases a day earlier, the health authority said. All of the new infections were imported cases, the National Health Commission said in a statement. There were no new deaths.

U.S. vaccine plans take shape but no let-up on restrictions

U.S. health authorities will hold an emergency meeting next week to recommend that a coronavirus vaccine awaiting approval be given first to healthcare professionals and people in long-term care facilities. The meeting, announced on Friday by a U.S. Centers for Disease Control and Prevention (CDC) committee on immunizations, suggests that the Food and Drug Administration (FDA) may be close to authorizing distribution of the long-awaited medication, at least to those considered most vulnerable.

Type O blood linked to lower COVID risk, taking Vitamin D unlikely to help

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Certain blood groups less likely to get COVID-19

(With inputs from agencies.)

Give Feedback